Cleveland BioLabs Reports First Quarter 2015 Financial Results and … – MarketWatch

Cleveland BioLabs Reports First Quarter 2015 Financial Results and
MarketWatch
The Company had 4.3 million common shares outstanding at March 31, 2015, assuming the full conversion of convertible preferred stock and the issuance of shares covered by pre-funded warrants issued in the February financing. In addition, the Company …

and more

…read more

Scroll to Top